Hormones

Phase 3Small molecule

DDavid Palma

Hormones is one of 3 small molecule programs targeting Metastatic Tumors. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Metastatic TumorsActive, not recruiting

Metastatic TumorsPhase 3

Active, not recruiting

Competition

Competitive Landscape

3 competitors in Metastatic Tumors

#DrugCompanyPhaseTrials

Immunotherapy

Bristol-Myers Squibb

Phase 3

1 2

Hormones

DDavid Palma

Phase 3

1 3

BAT1006

BBio-Thera Solutions

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2029

Phase 3Active, not recruiting

Metastatic Tumors

NCT03721341

Clinical

Trials by Indication[1]

Pneumonia2 trials

Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs

Unknown status·IInstitute of Cell Therapy·Phase 1/2·NCT04461925·30 enrolled

Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019

Unknown status·FFuzhou General Hospital·Phase 1·NCT04371601·60 enrolled

Function1 trial

Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity

Completed·MMedical University of Vienna··NCT01292785·80 enrolled

Clinical Trial1 trial

Climacteric Clinical Trial : the Use of Complementary Therapy and Hormonal Replacement

Unknown status·—·Phase 4·NCT00617500·278 enrolled

Metastatic Tumors1 trial

Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors

Active, not recruiting·DDavid Palma·Phase 3·NCT03721341·204 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Hormones. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Hormones compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Hormones. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — David Palma company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: DDavid Palma

Hormones

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2029

Trials by Indication[1]

Pneumonia2 trials

Function1 trial

Clinical Trial1 trial

Metastatic Tumors1 trial

References

Drug Info

Quick Facts

Related News